NRCIA News Alert National Research Corp (NRCIA) 14.60 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
National Research Corp (NRCIA) 14.60 $NRCIA

National Research posts 4Q profit
Automated Insights - Tue Feb 10, 6:54PM CST
LINCOLN, Neb. (AP) _ National Research Corp. (NRCIB) on Tuesday reported fourth-quarter profit of $4.1 million.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

National Research Corporation Announces Fourth Quarter and Year-End 2014 Results
GlobeNewswire - Tue Feb 10, 4:00PM CST
National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced results for the fourth quarter and year-end 2014.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

The Governance Institute Announces Renowned Dr. Atul Gawande as Keynote Speaker at Spring System Invitational in Early February
GlobeNewswire - Mon Feb 02, 1:05PM CST
The Governance Institute, a service of National Research Corporation, announces its Spring System Invitational entitled "Health System 2020: Building an Enduring Enterprise," to take place February 8-10 at the Four Seasons Hotel in Austin, Texas. The conference is designed exclusively for health system CEOs, executives, board members, and physician leaders.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

National Research Corporation to Broadcast Its 2014 Fourth Quarter Conference Call Live on the Internet
GlobeNewswire - Wed Jan 28, 3:37PM CST
National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced that it will provide an online Web simulcast of its 2014 fourth quarter conference call on Wednesday, February 11, 2015. The Company's results for the fourth quarter will be released after the close of the market on Tuesday, February 10, 2015.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

National Research Corporation: Confirming A Major Valuation Discrepancy
Denver Smith - at Seeking Alpha - Mon Jan 12, 10:32AM CST

NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

Nasdaq stocks posting largest volume decreases
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
INTG: 19.80 (+0.51), BDMS: 14.79 (-0.21), NRCIA: 14.60 (-0.24), COBK: 13.41 (unch), GRIF: 31.40 (+1.32), VYFC: 19.72 (+0.12), STRN: 5.33 (-0.04), LAMR: 57.55 (+0.16), ITIC: 78.97 (+3.88), CIZN: 18.80 (-0.07), IROQ: 16.70 (unch), NRCIB: 35.75 (+1.95), MFNC: 11.61 (+0.36)

SHAREHOLDER ALERT: The Wagner Firm Announces Investigation of the Board of Directors of National Research Corp.
Business Wire - Mon Dec 15, 10:00AM CST
The Wagner Firm announces that it is investigating the board of directors of National Research Corp. ("NRC" (NASDAQ:NRCIA and NASDAQ:NRCIB) for potential breaches of fiduciary duty.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

Nasdaq stocks posting largest percentage decreases
AP - Fri Dec 12, 12:18PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
NRCIA: 14.60 (-0.24), SOFO: 8.07 (-0.16), HCCI: 12.05 (-0.14), CZR: 10.78 (+0.18), NRCIB: 35.75 (+1.95), VNR: 18.09 (+0.38), OBAS: 6.25 (-0.05)

New Reputation Solution Enables Healthcare Organizations to Publish Physician Reviews Online
GlobeNewswire - Tue Dec 09, 6:12AM CST
National Research Corporation announced today the acquisition of Digital Assent and launch of its Reputation solution, which enables healthcare organizations to collect, display, and syndicate authentic patient ratings and reviews across owned and affiliated websites.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

National Research declares $0.06/share quarterly dividend.
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 10:20PM CST

NRCIA: 14.60 (-0.24)

National Research Corporation Declares Quarterly Dividend
GlobeNewswire - Mon Dec 08, 8:30PM CST
National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 (six cents) per Class A share and $.36 (thirty-six cents) per Class B share payable Thursday, January 15, 2015, to shareholders of record as of the close of business on Wednesday, December 31, 2014.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

Intrepid USA Honored As Elite Home Health Care Provider For Ninth Consecutive Year
PR Newswire - Thu Nov 20, 10:00AM CST
For the ninth consecutive year, Intrepid USA Healthcare Services (Intrepid) has been identified as one of the top-performing home health agencies in the United States. Based on a review by two national performance and patient satisfaction measurement companies, National Research Corporation (NRC) and DecisionHealth, Intrepid was named among the HomeCare Elite(TM), taking its place in the top 25 percent of agencies nationwide.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)

2014 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide
GlobeNewswire - Wed Nov 05, 10:00AM CST
Amedisys, a leading healthcare at home company (Nasdaq:AMED), today announced that 162 of its care centers across the country have been named to the 2014 HomeCare Elite(TM), a compilation of the top-performing home health agencies in the United States compiled annually by OCS Home Care and DecisionHealth.
NRCIA: 14.60 (-0.24), AMED: 28.62 (+0.16), NRCIB: 35.75 (+1.95)

National Research EPS of $0.11
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:44PM CST

NRCIA: 14.60 (-0.24)

National Research Corporation Announces Third Quarter 2014 Results
GlobeNewswire - Tue Nov 04, 4:00PM CST
National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced results for the third quarter of 2014.
NRCIA: 14.60 (-0.24), NRCIB: 35.75 (+1.95)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Fnac Darty Reports Share Buyback Transactions for June 2025

Updated Category News Views 243

Fnac Darty's Own Share Transactions Overview Recently, the renowned retail group Fnac Darty disclosed its trading activities involving shares from June 23 to June 27, 2025. This announcement is part of its continued commitment to transparency in its financial operations and shareholder communications. Significance of Share Buybacks Buyback programs are strategic moves for...

Continue Reading
Reboot Studios Announces Innovative Jewish Media Projects for 2024

Updated Category News Views 273

Reboot Studios Unveils Exciting Jewish Media Projects for 2024 A New Chapter in Jewish Storytelling Reboot Studios, which is dedicated to empowering creators and artists, has announced the projects that will be part of its 2024 Creator Fund lineup. This latest funding round builds on previous achievements, including the Oscar-shortlisted dark comedy The Anne Frank Gift...

Continue Reading
Sigrid Therapeutics Advances Diabetes Management with SiPore® Food

Updated Category News Views 244

Innovative Access to SiPore® Technology Sigrid Therapeutics is thrilled to share that it has successfully secured U.S. market access for its groundbreaking SiPore® technology following the impressive results from the SHINE study, which is recognized as the largest study of its kind in prediabetes. About the SHINE Study The SHINE study provided pivotal insights into the...

Continue Reading
Strategic Investment by Cordatus Capital in Red Dot Buildings

Updated Category News Views 865

Cordatus Capital's Strategic Move to Partner with Red Dot Buildings Cordatus Capital is thrilled to announce a significant majority investment in Red Dot Buildings, a pioneering manufacturer of complex metal building systems. This partnership marks a premier opportunity for both Cordatus and Red Dot to leverage their strengths and drive substantial growth. Red Dot is...

Continue Reading
Class Action Alerts: Opportunities for LULU, F, XPEL, and EXTR Investors

Updated Category News Views 107

Understanding Recent Class Action Lawsuits for Major Companies Investors often find themselves unsure about how corporate decisions might affect their finances. Recently, a number of well-known companies have been caught up in class action lawsuits, which can have serious implications for shareholders. It's important for investors to grasp their legal position and explore...

Continue Reading